Biodegradable Nanocomplex Radial Charge Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional drug carriers, such as liposomes, face challenges in achieving uniform particle size and stability, leading to inefficient immune response modulation and potential aggregation issues.
Innovation Solution
A biodegradable nanocomplex with a nonuniformly positive charge distribution along its radial direction, composed of a first electrically charged substance, a charge-redistribution substance, and a second electrically charged substance, which holds a carried substance inside and modulates immune responses effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional liposome carriers are used, then drug encapsulation is achieved, but particle size uniformity deteriorates and aggregation occurs
Solution Approach 1:
The patent uses composite materials by combining multiple charged substances (first electrically charged substance, charge-redistribution substance, and second electrically charged substance) to form a nanocomplex with nonuniform positive charge distribution. This composite structure achieves both uniform particle size (50-200 nm) and enhanced stability, resolving the contradiction between manufacturing precision and composition stability.
Solution Approach 2:
The patent applies local quality by creating a nonuniform charge distribution within the nanocomplex structure. The charge density varies along the radial direction, with higher density at certain regions and lower density at others. This localized charge variation enables controlled particle size uniformity while maintaining overall structural stability, preventing aggregation.
2Productivity
If traditional macromolecular carriers are used, then drug delivery is achieved, but immune response modulation efficiency deteriorates
Solution Approach 1:
The patent changes key parameters including charge distribution (nonuniform positive charge), particle size (50-200 nm), and zeta potential (optimized range) to enhance immune response modulation efficiency. These parameter optimizations simultaneously improve delivery efficiency by ensuring stable circulation and targeted delivery, resolving the contradiction between productivity and reliability.
Solution Approach 2:
The patent introduces dynamics through the charge-redistribution substance that can adjust charge distribution in response to environmental conditions. This dynamic charge adjustment capability enhances immune response modulation while maintaining reliable drug delivery, as the nanocomplex can adapt to different physiological environments during circulation and target delivery.
3Adaptability or versatility
If uniform charge distribution is used in nanocomplex, then structural simplicity is maintained, but immune response modulation deteriorates
Solution Approach 1:
The patent deliberately introduces charge distribution complexity through local quality variations. The nonuniform positive charge distribution (with different charge densities in different radial regions) provides enhanced immune response modulation capability by creating specific electrostatic interactions with immune cells, while the overall nanocomplex structure remains relatively simple and manufacturable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biodegradable nanocomplex achieves a uniform particle size with reduced standard deviation, enhances immune response modulation, and improves the stability and delivery efficiency of carried substances, such as proteins and vaccines, while avoiding aggregation and providing sustained release.
Implementation Method 1
the biodegradable nanocomplex has a nonuniformally and positively charge distribution along a radial direction thereof, for holding a carried substance inside
Data Source
AI summary
The present invention relates to a biodegradable nanocomplex. The biodegradable nanocomplex comprises a first electrically charged substance, a charge-redistribution substance, a second electrically charged substance and a carried substance, for holding the carried substance inside. The first electrically charged substance and the carried substance have the same electrical polarity, and the biodegradable nanocomplex has a nonuniformally and positively charge distribution along a radial direction thereof. The nonuniformally and positively charge distribution comprises a first electrically charged portion having substantially electrical neutrality, a second electrically charged portion surrounding the first electrically charged portion, and a third electrically charged portion surrounding the second electrically charged portion, in which the third electrically charged portion comprises an outermost surface of the biodegradable nanocomplex, thereby modulating the carried substance towards the desired immune responses via the nonuniformally and positively charge distribution.